You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study

Article metrics

Article menu

Download PDFPDF

XML
Research
Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study

 

Online download statistics by month:

Online download statistics by month: April 2018 to March 2024

AbstractFullPdf
Apr 201810371039144
May 2018820831137
Jun 201819819721
Jul 2018515121
Aug 2018686823
Sep 201811811834
Oct 2018898920
Nov 201818818835
Dec 201819519531
Jan 201916115725
Feb 201917217030
Mar 201913013022
Apr 201929629554
May 201911411523
Jun 2019888823
Jul 2019636419
Aug 2019939222
Sep 201910110119
Oct 201912712723
Nov 201911811921
Dec 2019939326
Jan 202011611628
Feb 202012312129
Mar 2020929022
Apr 202012612414
May 20201009916
Jun 2020787814
Jul 2020363617
Aug 202066676
Sep 202082838
Oct 2020898828
Nov 2020747216
Dec 202070697
Jan 202112612620
Feb 202111811821
Mar 202110910812
Apr 202110310319
May 20219910012
Jun 2021636414
Jul 2021626218
Aug 2021575711
Sep 202173736
Oct 2021626235
Nov 2021777825
Dec 2021424612
Jan 2022495210
Feb 2022434614
Mar 2022626612
Apr 2022929710
May 2022767917
Jun 2022535611
Jul 2022464510
Aug 2022727214
Sep 2022798224
Oct 2022767611
Nov 2022797931
Dec 202255558
Jan 2023475117
Feb 2023828415
Mar 202360637
Apr 2023767910
May 2023606015
Jun 202341415
Jul 2023444418
Aug 2023596114
Sep 2023585912
Oct 2023656912
Nov 202310811315
Dec 2023929311
Jan 2024525212
Feb 2024525219
Mar 2024717321
Total811281661558